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Abstract
Background: It has been shown that microalbuminuria is an independent risk factor for
cardiovascular diseases in diabetetics, hypertensive patients and in the general population.
However, few data has addressed the correlation of microalbuminuria with the severity of
coronary artery disease (CAD). The aim of the study was to assess the association of
microalbuminuria with the prevalence and severity of CAD.
Methods: The subjects, 79 men and 74 women aged 45–70 years, were classified as CAD-
-negative and CAD-positive according to the results of coronary angiography. The severity of
CAD was scored on the basis of the number and the extent of lesions within the coronary arteries.
Urine albumin excretion was measured in 24 h urine samples by method of nephelometry.
Results: Coronary artery disease occurred more frequently in males than in females and in
smokers than in non-smokers. There were no significant differences in the prevalence of
hypertension and hypercholesterolemia between two groups. Microalbuminuria was more
prevalent in CAD-positive patients than in controls (62.9% vs. 8.8%; p £ 0.001). Patients
with microalbuminuria compared with the controls had increased prevalence of one (15.3%
vs. 7.4%, p £ 0.001), two (50% vs. 22.2%, p £ 0.001), and three vessel disease (29.2% vs.
19.8%, p £ 0.001). Microalbuminuria exhibited a significant correlation with the severity of
CAD (r = 0.40; p £ 0.001).
Conclusions: Patients with microalbuminuria have more severe angiographically detected
CAD than those without microalbuminuria. The results indicate that microalbuminuria
exhibits a significant association with the presence and severity of CAD. (Cardiol J 2009; 16,
2: 142–145)
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Introduction
Coronary artery disease (CAD) is a multifac-
torial disorder with several different risk factors [1].
Advancing age, male sex, hypertension, diabetes
mellitus, cigarette smoking and dyslipidemia are the
major and independent risk factors for CAD [1].
However, they do not entirely explain the variation
in cardiovascular disease incidence and mortality
between individuals and among populations [1].
Therefore, additional risk factors have been propo-
sed to better identify patients potentially at risk for
CAD, and urinary albumin is candidate.
It is reported that microalbuminuria is associa-
ted with all causes of cardiovascular morbidity and
mortality in patients with diabetes [2, 3], hyperten-
sion [4, 5] and in the general population [6–10].
Some studies have also shown that this correlation
is independent of renal function, hypertension, and
diabetes [10, 11]. The association between albuminu-
ria and cardiovascular events is well recognized [12],
but few studies have addressed its correlation with
the severity of CAD. This study was undertaken to
investigate the relation between microalbuminuria
and the prevalence and severity of angiographical-
ly confirmed CAD in nondiabetic patients.
Methods
The study population consisted of 79 men and
74 women at the mean age of 57 ± 11 years in whom
CAD was suspected and who were consecutively
referred and underwent their first coronary angio-
graphy at FatemeZahra hospital of university of
Mazandaran between January–June of 2007. The
individuals with a recent history of acute myocar-
dial infarction, precutaneous transluminal corona-
ry angioplasty and renal, infectious, and malignant
disease or diabetes were excluded. Patients who
were receiving atenolol, and angiotensin converting
enzyme inhibitors and angiotensin receptor anta-
gonists were not included in the study either, due
to possible effect on urine albumin excretion. The
data were collected on demographic and major car-
diovascular risk factors including age, hypertension,
diabetes mellitus, smoking and serum fasting glu-
cose and lipids. Urinary albumin concentration was
measured by method of nephelometry using the
Behring protein kit. The ratio of urine albumin to
creatinine was used to define microalbuminuria.
Patients with albumin levels less than 30 mg/g of
creatinine were defined as having normoalbuminu-
ria, those with albumin levels 30–300 mg/g as ha-
ving microalbuminuria. CAD was defined significant
if there was ≥ 50% diameter stenosis in ≥ 1 major
coronary artery. Diagnosis of diabetes mellitus was
based on abnormal fasting blood glucose ≥ 126 mg/dL
or the use of hypoglycemic agents. Patients who
received medication for hypertension or those with
systolic blood pressure ≥ 140 mm Hg and or dia-
stolic blood pressure ≥ 90 mm Hg were classified
as having hypertension. Hypertensive diabetic pa-
tients were defined as systolic ≥ 130/80 mm Hg.
Patients who had smoked within one year of entry
into the study were deemed as current smokers.
Patients who used cholesterol lowering medication
or had a total serum cholesterol level ≥ 200 mg/dL
were classified as having hypercholesterolemia.
The study was approved by the local bioethical
committee and all patients gave their informed consent.
Chi-square and two-tailed t-tests were used to
examine baseline differenced between two propor-
tions or means using SPSS software (version 13).
All p-values are two-tailed and differences were
considered significant if p-values were £ 0.05.
Results
Anthropometric and clinical
characteristics of participants
The results of angiography showed that there
were 45 CAD-negative patients (normal or stenosis
< 50%) and 108 as CAD-positive patients (stenosis
> 50%). Among the patients with CAD, 17 had one-
-vessel, 54 two-vessel and 37 three-vessel disease. The
mean age was similar between the two groups of pa-
tients (Table 1). Coronary artery disease occurred more
frequently in males than in females and in smokers than
in non-smokers. There were no significant differences
in the prevalence of hypertension and hypercholeste-
rolemia between the two groups. Microalbuminuria
was more prevalent in CAD patients than in controls.
Microalbuminuria and the severity
of coronary artery disease
The patients were divided into two groups ac-
cording to the absence (negative) and presence (po-
sitive) of microalbuminuria. The severity of CAD
was scored on the basis of the number and the
extent of lesions in the coronary arteries as normal,
one, two and three-vessel disease. The distribution
of CAD severity in the groups with and without
microalbuminuria was presented in Table 2. The
results show thatin patients with microalbuminu-
ria compared with the controls the prevalence of
one, two, and three vessel disease was increased.
Microalbuminuria exhibited a significant correlation
with the severity of CAD (r = 0.40; p £ 0.001).
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Discussion
The results of the present study showed that
microalbuminuria was more prevalent in CAD patients
compared to controls. In addition, the patients with
microalbuminuria had much greater atherosclerotic
burden in the form of multi-vessel disease than those
without microalbuminuria. The results are in accor-
dance with the previously reported findings [4–10].
It is proposed that microalbuminuria indicates
early and possibly reversible glomerular damage [4].
In general, microalbuminuria is associated with
hypertension, diabetes mellitus and renal dysfunc-
tion. Microalbuminuria predicts cardiovascular
events and renal insufficiency in hypertensive pa-
tients [3–5, 13]. In diabetic patients, microalbumi-
nuria is associated with four-six fold increase in risk
of cardiovascular mortality [6, 14, 15]. This corre-
lation was also confirmed in the apparently healthy
general population [7–9, 11]. However, some stu-
dies have shown that the association of microalbu-
minuria with CAD is independent of hypertension,
diabetes and renal function [10].
The mechanism whereby microalbuminuria
accelerates atherosclerosis is uncertain. Abnormal
vasodilatation [16], endothelial dysfunction [17, 18],
inflammation [19], insulin resistance or abnormal
coagulation may be involved [19, 20]. It seems that
aggressive treatment of microalbuminuria is bene-
ficial in CAD patients. Ibsen et al. showed that
a decrease in baseline albuminuria, which was more
significant with losartan than with atenolol, is ac-
companied with significant reduction in cardiova-
scular events [21, 22]. Asselbergs et al. [23] have
shown that in normotensive patients followed for
4 years, fosinopril was associated with a significant
trend toward a lower rate of cardiovascular morta-
lity and hospitalization.
In conclusion, the results of the present study
indicate that microalbuminuria is associated with the
prevalence and severity of CAD. However, due to
cross-sectional nature of this study a causal relation-
ship cannot be established. Prospective studies are
needed to determine with certainty the degree of risk
of CAD associated with microalbuminuria.
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Table 1. Patients’ demographics and prevalence of coronary artery disease (CAD) risk factors.
Variables CAD (negative) CAD (positive) P
N 45 108
Age (years) 58 ± 9.8 58 ± 11 0.950
Sex (male/female) 18/27 62/46 0.053
Smokers 4.4% (2) 11.2% (12) 0.235
Hypertension 35.6% (16) 38.8% (42) 0.699
Hypercholesterolemia 33.3% (15) 35.1% (38) 0.826
Microalbuminuria 8.08% (4) 62.9% (68) < 0.001
One-vessel: 125 ± 20 0.00010
Urine albumin [mg/g] 48 ± 10 Two-vessel: 132 ± 11 0.00010
Three-vessel: 148 ± 18 0.0001
Diuretics 86% 89%
Beta-blocker (metoprolol) 70% 84%
Calcium-c-b 66% 68%
Aspirin 25% 100%
P values for all data between the two groups were not significant
Table 2. Prevalence of one-, two-, and three-vessel
coronary artery disease (CAD) in the presence
and absence of microalbuminuria.
CAD severity MA– MA+ P
Normal CAD 50.6% (41) 5.6% (4) –
One-vessel 7.7% (6) 15.3% (11) 0.001
Two-vessel 22.2% (18) 50.0% (36) 0.001
Three-vessel 19.8% (16) 29.2% (21) 0.001
MA– and MA+ presence and absence of microalbuminuria
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